Clinical Trial Update: Use of Autologous Stem/Stromal Cells In Chronic Lung Disorders: Obstructive (COPD) & Restrictive (RLD) [Phase 1]

View source ↗

Summary

Phase 1 trial using autologous stem/stromal cells for COPD and restrictive lung disease is suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Respiratory Insufficiency
• Restrictive Lung Disease

Drugs mentioned

• Autologous stem/stromal cells

Snippet

Sponsor: Healeon Medical Inc | Conditions: COPD, Respiratory Insufficiency | Phase 1 | Status: SUSPENDED